Rosiglitazone promotes fatty acyl CoA accumulation and excessive glycogen storage in livers of mice without adiponectin

被引:21
作者
Zhou, Mingyan [1 ]
Xu, Aimin [1 ,2 ]
Lam, Karen S. L. [1 ,2 ]
Tam, Paul K. H. [3 ]
Che, Chi-Ming [4 ]
Chan, Lawrence [5 ,6 ]
Lee, In-Kyu [7 ]
Wu, Donghai [8 ]
Wang, Yu [1 ,3 ,8 ]
机构
[1] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China
[4] Univ Hong Kong, Open Lab Chem Biol, Inst Mol Technol Drug Discovery & Synth, Hong Kong, Hong Kong, Peoples R China
[5] Baylor Coll Med, Dept Med, Div Endocrinol Diabet & Metab, Houston, TX 77030 USA
[6] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[7] Kyungpook Natl Univ, Sch Med, Taegu, South Korea
[8] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China
基金
美国国家卫生研究院;
关键词
Liver injury; Adiponectin; Rosiglitazone; Mitochondria; Uncoupling protein 2; HEPATIC INSULIN SENSITIVITY; PLACEBO-CONTROLLED TRIAL; TYPE-2; DIABETIC-PATIENTS; NONALCOHOLIC STEATOHEPATITIS; POSTTRANSLATIONAL MODIFICATIONS; LACKING ADIPONECTIN; LIPID-METABOLISM; BETA-OXIDATION; MOUSE MODEL; THIAZOLIDINEDIONES;
D O I
10.1016/j.jhep.2010.05.034
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims The beneficial effects of rosiglitazone on non-alcoholic fatty liver disease (NAFLD) have been reported Rosiglitazone treatment stimulates the production of adiponectin an insulin-sensitizing adipokine with hepatoprotective functions The present study aims to investigate the hepatic actions of rosiglitazone in mice without adiponectin Methods NAFLD was induced in wild type and adiponectin knockout (AKO) mice by high-fat diet feeding After rosiglitazone treatment mice were subjected to evaluations on systemic insulin sensitivity lipid profiles hepatic steatosis and inflammation as well as the expression and activity of key molecules Involved in energy metabolism and mitochondrial functions Results Rosightazone treatment prevented hepatic inflammation and reduced the expression of pro-inflammatory cytokines in livers of wild type mice In contrast in livers of AKO mice the same treatment induced severe hepatomegaly and microvesicular hepatosteatosis and caused abnormal accumulation of fatty acyl CoA glycogen and their intermediate metabolites Compared to wild type littermates the anti-inflammatory and the mitochondria-stimulatory activity of rosiglitazone were largely attenuated in AKO mice Replenishment with either adiponectin or uncoupling protein 2 (UCP2) significantly reduced fatty acyl CoA accumulation and increased mitochondrial activities in livers of rosiglitazone-treated AKO mice In addition adiponectin but not UCP2 promoted the activation of glycogen synthase kinase 3beta (GSK3beta) a key molecule Involved in regulating glycogen homeostasis Conclusions Rosiglitazone elicits its protective functions against NAFLD largely through the induction of adiponectin which prevents mitochondria stresses by promoting GSK3beta activation and UCP2 upregulation two pathways coordinating the glucose and lipid metabolism in liver (C) 2010 European Association for the Study of the Liver Published by Elsevier B V All rights reserved
引用
收藏
页码:1108 / 1116
页数:9
相关论文
共 49 条
  • [11] Adiponectin:: a relevant player in PPARγ-agonist-mediated improvements in hepatic insulin sensitivity?
    Bouskila, M
    Pajvani, UB
    Scherer, PE
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2005, 29 (Suppl 1) : S17 - S23
  • [12] Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3
    Brand, MD
    Esteves, TC
    [J]. CELL METABOLISM, 2005, 2 (02) : 85 - 93
  • [13] Caldwell SH, 2007, HEPATOLOGY, V46, p741A
  • [14] Rosiglitazone-induced granulomatous hepatitis
    Dhawan, M
    Agrawal, R
    Ravi, J
    Gulati, S
    Silverman, J
    Nathan, G
    Raab, S
    Brodmerkel, G
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 34 (05) : 582 - 584
  • [15] Pharmacological treatment of non-alcoholic steatohepatitis: The current evidence
    Diakou, Maria C.
    Liberopoulos, Evangelos N.
    Mikhailidis, Dimitri P.
    Tsianos, Epaminondas V.
    Burroughs, Andrew K.
    Elisaf, Moses S.
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (02) : 139 - 147
  • [16] The roles of leptin and adiponectin: A novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology
    Ding, XK
    Saxena, NK
    Lin, SB
    Xu, A
    Srinivasan, S
    Anania, FA
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2005, 166 (06) : 1655 - 1669
  • [17] The mitochondrial trifunctional protein:: centre of a β-oxidation metabolon?
    Eaton, S
    Bursby, T
    Middleton, B
    Pourfarzam, M
    Mills, K
    Johnson, AW
    Bartlett, K
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2000, 28 : 177 - 182
  • [18] FOLCH J, 1957, J BIOL CHEM, V226, P497
  • [19] Liver failure in a patient treated with long-term rosiglitazone therapy
    Gouda, HE
    Khan, A
    Schwartz, J
    Cohen, RI
    [J]. AMERICAN JOURNAL OF MEDICINE, 2001, 111 (07) : 584 - 585
  • [20] GUARDIA NR, 2008, DIABETES OBES METAB, V10, P367